Cameron P Upchurch1, Carlos G Grijalva2, Stephan Russ3, Sean P Collins3, Matthew W Semler4, Todd W Rice4, Dandan Liu5, Jesse M Ehrenfeld6, Kevin High3, Tyler W Barrett3, Candace D McNaughton3, Wesley H Self7. 1. School of Medicine, Vanderbilt University Medical Center, Nashville, TN. 2. Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN. 3. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN. 4. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. 5. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. 6. Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN. 7. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address: wesley.self@vanderbilt.edu.
Abstract
STUDY OBJECTIVE: Induction doses of etomidate during rapid sequence intubation cause transient adrenal dysfunction, but its clinical significance on trauma patients is uncertain. Ketamine has emerged as an alternative for rapid sequence intubation induction. Among adult trauma patients intubated in the emergency department, we compare clinical outcomes among those induced with etomidate and ketamine. METHODS: The study entailed a retrospective evaluation of a 4-year (January 2011 to December 2014) period spanning an institutional protocol switch from etomidate to ketamine as the standard induction agent for adult trauma patients undergoing rapid sequence intubation in the emergency department of an academic Level I trauma center. The primary outcome was hospital mortality evaluated with multivariable logistic regression, adjusted for age, vital signs, and injury severity and mechanism. Secondary outcomes included ICU-free days and ventilator-free days evaluated with multivariable ordered logistic regression using the same covariates. RESULTS: The analysis included 968 patients, including 526 with etomidate and 442 with ketamine. Hospital mortality was 20.4% among patients induced with ketamine compared with 17.3% among those induced with etomidate (adjusted odds ratio [OR] 1.41; 95% confidence interval [CI] 0.92 to 2.16). Patients induced with ketamine had ICU-free days (adjusted OR 0.80; 95% CI 0.63 to 1.00) and ventilator-free days (adjusted OR 0.96; 95% CI 0.76 to 1.20) similar to those of patients induced with etomidate. CONCLUSION: In this analysis spanning an institutional protocol switch from etomidate to ketamine as the standard rapid sequence intubation induction agent for adult trauma patients, patient-centered outcomes were similar for patients who received etomidate and ketamine.
STUDY OBJECTIVE: Induction doses of etomidate during rapid sequence intubation cause transient adrenal dysfunction, but its clinical significance on trauma patients is uncertain. Ketamine has emerged as an alternative for rapid sequence intubation induction. Among adult trauma patients intubated in the emergency department, we compare clinical outcomes among those induced with etomidate and ketamine. METHODS: The study entailed a retrospective evaluation of a 4-year (January 2011 to December 2014) period spanning an institutional protocol switch from etomidate to ketamine as the standard induction agent for adult trauma patients undergoing rapid sequence intubation in the emergency department of an academic Level I trauma center. The primary outcome was hospital mortality evaluated with multivariable logistic regression, adjusted for age, vital signs, and injury severity and mechanism. Secondary outcomes included ICU-free days and ventilator-free days evaluated with multivariable ordered logistic regression using the same covariates. RESULTS: The analysis included 968 patients, including 526 with etomidate and 442 with ketamine. Hospital mortality was 20.4% among patients induced with ketamine compared with 17.3% among those induced with etomidate (adjusted odds ratio [OR] 1.41; 95% confidence interval [CI] 0.92 to 2.16). Patients induced with ketamine had ICU-free days (adjusted OR 0.80; 95% CI 0.63 to 1.00) and ventilator-free days (adjusted OR 0.96; 95% CI 0.76 to 1.20) similar to those of patients induced with etomidate. CONCLUSION: In this analysis spanning an institutional protocol switch from etomidate to ketamine as the standard rapid sequence intubation induction agent for adult trauma patients, patient-centered outcomes were similar for patients who received etomidate and ketamine.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Adil H Haider; Taimur Saleem; Jeffrey J Leow; Cassandra V Villegas; Mehreen Kisat; Eric B Schneider; Elliott R Haut; Kent A Stevens; Edward E Cornwell; Ellen J MacKenzie; David T Efron Journal: J Am Coll Surg Date: 2012-02-07 Impact factor: 6.113
Authors: Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin Journal: Lancet Date: 2007-04-07 Impact factor: 79.321
Authors: Julia Dixon; Grant Comstock; Jennifer Whitfield; David Richards; Taylor W Burkholder; Noel Leifer; Nee-Kofi Mould-Millman; Emilie J Calvello Hynes Journal: Afr J Emerg Med Date: 2020-06-16
Authors: Wesley H Self; Matthew W Semler; Jonathan P Wanderer; Li Wang; Daniel W Byrne; Sean P Collins; Corey M Slovis; Christopher J Lindsell; Jesse M Ehrenfeld; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice Journal: N Engl J Med Date: 2018-02-27 Impact factor: 91.245
Authors: Nicholas M Mohr; Stephen G Pape; Dan Runde; Amy H Kaji; Ron M Walls; Calvin A Brown Journal: Acad Emerg Med Date: 2020-07-20 Impact factor: 3.451
Authors: Wesley H Self; Matthew W Semler; Jonathan P Wanderer; Jesse M Ehrenfeld; Daniel W Byrne; Li Wang; Leanne Atchison; Matthew Felbinger; Ian D Jones; Stephan Russ; Andrew D Shaw; Gordon R Bernard; Todd W Rice Journal: Trials Date: 2017-04-13 Impact factor: 2.279
Authors: Julie A Dunn; Thomas J Schroeppel; Michael Metzler; Chris Cribari; Katherine Corey; David R Boyd Journal: Trauma Surg Acute Care Open Date: 2018-10-09
Authors: Jung Min Lee; Geeho Min; Jae Min Lee; Seung Han Kim; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen; Hoon Jai Chun; Hong Sik Lee; Chang Duck Kim; Jong-Jae Park; Beom Jae Lee; Seong Ji Choi; Woojung Kim Journal: Medicine (Baltimore) Date: 2018-05 Impact factor: 1.889